The Centers for Medicare & Medicaid Services (CMS) has expanded the list of telehealth services that Medicare Fee For Service will pay during the COVID-19 pandemic. The list of 11 services includes neurostimulator programming and monitoring, cardiac rehabilitation, and pulmonary rehabilitation.

​The FDA’s Center for Devices and Radiological Health (CDRH) has announced a game changer for the future of digital health technology, by establishing the agency’s Digital Health Center of Excellence (DHCoE). The new center is intended to provide “centralized expertise” and serve as a resource for digital health technologies and policy for digital health innovators, the public, and FDA staff, according to the agency, allowing it to pursue a “comprehensive approach to digital health technology.”

Thanks to their role using, managing, and repairing medical devices, healthcare technology management (HTM) professionals are crucial providers of voluntary feedback to the FDA about the health technology they’re using every day. In a Sept. 22 HTM Live! webinar, FDA representatives described how they can use the agency’s Medical Product Safety Network (MedSun) to do just that.